Data / Form D filings / Aegle Therapeutics Corp
Aegle Therapeutics Corp: Form D filings
Aegle Therapeutics Corp, a biotechnology company in Woburn, MA, filed 5 Form D notices with the SEC between 2020 and 2026. The latest, on August 28, 2026, reports $2.3 million sold of a $2.3 million offering to 17 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 TRADECENTER SUITE 5900, Woburn, MA, 01801
- Phone
- (781) 918-8449
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1797825
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | New notice | $2,277,698 | $2,277,698 | 17 | Aug 4, 2026 | sec.gov | |
| Mar 3, 2026 | New notice | $700,000 | $455,695 | $244,305 | 10 | Dec 30, 2025 | sec.gov |
| Jul 28, 2020 | Amendment | $6,500,000 | $6,500,000 | 8 | Jan 3, 2020 | sec.gov | |
| May 14, 2020 | Amendment | $6,000,000 | $5,000,000 | $1,000,000 | 8 | Jan 3, 2020 | sec.gov |
| Jan 7, 2020 | New notice | Indefinite | $4,010,000 | 7 | Jan 3, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Shelley Hartman | Executive Officer, Director | |
| Scott Braunstein | Director | |
| Leon Moulder | Director | |
| Evangelos Badiavas | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 24, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Aegle Therapeutics Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.